KASHI CLINICAL LABORATORIES, LLC

KASHI CLINICAL LABORATORIES, INC. operates as a clinical laboratory services provider specializing in diagnostic testing and laboratory support functions for government health programs. Based on its NAICS classification of 621511, the company delivers clinical pathology services including specimen analysis, laboratory information system management, quality control protocols, and regulatory-compliant reporting. Their technical expertise centers on high-complexity testing procedures, CLIA certification adherence, and compliance with federal laboratory standards such as those enforced by the Centers for Medicare & Medicaid Services. The firm’s operational model emphasizes accuracy, turnaround efficiency, and audit-ready documentation for public health initiatives. No agency award history is available to identify specific federal partners or recurring program engagements. Consequently, there is insufficient data to characterize relationship patterns with any federal department or agency. The company’s primary industry focus is clinical laboratory services under NAICS 621511, which encompasses diagnostic testing for infectious diseases, hematology, chemistry, immunology, and molecular diagnostics. In practice, this means the organization supports public health surveillance, preventive screening, and clinical decision-making through accredited laboratory operations. Their market positioning is that of a specialized provider in the federal healthcare diagnostics space, serving programs requiring precise, timely, and compliant laboratory outcomes. KASHI CLINICAL LABORATORIES, INC. is structured as a small business (2L entity) headquartered in Portland, Oregon. The company holds no active government certifications such as 8(a), HUBZone, or WOSB. Its geographic footprint is limited to its operational base in Oregon, with no public indication of multi-state or nationwide federal service delivery. The firm’s government market presence is defined by its capacity to deliver clinical lab services under federal health contracting frameworks, though its specific program involvements cannot be determined from available award data.